Search Results - "Nordbrock, E"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain by Christie, J M, Simmonds, M, Patt, R, Coluzzi, P, Busch, M A, Nordbrock, E, Portenoy, R K

    Published in Journal of clinical oncology (01-10-1998)
    “…Supplemental, "as-needed," administration of an opioid is a common approach to the problem of breakthrough pain in cancer patients. Oral transmucosal fentanyl…”
    Get more information
    Journal Article
  2. 2

    Single and multiple oral dose pharmacokinetics of clentiazem in normal volunteers by Bhargava, V O, Shah, A K, Weir, S J, Nordbrock, E E, Giesing, D H

    Published in Journal of clinical pharmacology (01-05-1993)
    “…This study was designed to determine the pharmacokinetics and dose proportionality of clentiazem (CLZ) after single doses (SD) of 20, 40, and 80 mg and…”
    Get more information
    Journal Article
  3. 3

    Oral transmucosal fentanyl citrate : Randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer Patients by FARRAR, J. T, CLEARY, J, RAUCK, R, BUSCH, M, NORDBROCK, E

    “…Patients with cancer frequently experience episodes of acute pain, i.e., breakthrough pain, superimposed on their chronic pain. Breakthrough pain is usually…”
    Get full text
    Journal Article
  4. 4

    Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study by Portenoy, R K, Payne, R, Coluzzi, P, Raschko, J W, Lyss, A, Busch, M A, Frigerio, V, Ingham, J, Loseth, D B, Nordbrock, E, Rhiner, M

    Published in Pain (Amsterdam) (01-02-1999)
    “…Oral transmucosal fentanyl citrate (OTFC) is a novel opioid formulation in which the potent synthetic mu-agonist fentanyl is embedded in a sweetened matrix…”
    Get more information
    Journal Article
  5. 5

    The relative potency of oral transmucosal fentanyl citrate compared with intravenous morphine in the treatment of moderate to severe postoperative pain by LICHTOR, J. L, SEVARINO, F. B, JOSHI, G. P, BUSCH, M. A, NORDBROCK, E, GINSBERG, B

    Published in Anesthesia and analgesia (01-09-1999)
    “…Pharmacokinetic studies have shown that oral transmucosal absorption of fentanyl is relatively rapid compared with gastrointestinal absorption, and it results…”
    Get full text
    Journal Article
  6. 6

    Statistical comparison of stability study designs by Nordbrock, E

    “…Studies are routinely conducted during development of a new drug to investigate the effect of strength, package, batch, storage condition, and storage time on…”
    Get more information
    Journal Article
  7. 7

    Oral transmucosal etomidate in volunteers by STREISAND, J. B, JAARSMA, R. L, GAY, M. A, BADGER, M. J, MALAND, L, NORDBROCK, E, STANLEY, T. H

    Published in Anesthesiology (Philadelphia) (1998)
    “…The oral transmucosal route of delivery is now used for many drugs, including fentanyl and midazolam. Etomidate's pharmacokinetic profile and physiochemical…”
    Get full text
    Journal Article
  8. 8

    Population pharmacokinetics of teicoplanin in patients with endocarditis by Yu, D K, Nordbrock, E, Hutcheson, S J, Lewis, E W, Sullivan, W, Bhargava, V O, Weir, S J

    “…Teicoplanin is a new glycopeptide antibiotic, active against aerobic and anaerobic gram-positive bacteria. The drug is intended for the treatment of systemic…”
    Get more information
    Journal Article
  9. 9